oNKord®

· Glycostem Therapeutics BV

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for oNKord®, covering 2022-06-21 to 2022-06-21. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia [Phase 1, Phase 2]